Clachar HG

Idioma: Español
Referencias bibliográficas: 20
Paginas: 483-486
Archivo PDF: 243.44 Kb.

RESUMEN

El SPM representa una causa de consulta ginecológica muy frecuente, debido al comportamiento poblacional actual su diagnóstico es cada día mayor. La evaluación consiste en un método que incluya características específicas de cada paciente, examen físico y una valoración en conjunto de las diferentes pruebas diagnósticas disponibles. El USTV por su especificidad para detectar patología endometrial, nos determinará el plan diagnóstico y la identificación de enfermedad grave.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Albers J et al. Abnormal Uterine Bleeding. American Family Physician. 2004; 69: 1915-26

2. Astrup K, Olivarius NF. Frequency of spontaneously occurring postmenopausal bleeding in the general population. Acta Obstet Gynecol Scand 2004;83 (Feb (2)):203–7.

3. Bachmann G, Santen RJ. Treatment vaginal atrophy. In: UpToDate, Barbieri, RL (Ed), UpToDate, Waltham, MA, 2012

4. Breijer M. et al. Review Article - Diagnostic Strategies for Postmenopausal Bleeding. Obstetrics and Gynecology International Volume 2010 (2010)

5. Buchanan E et al. Endometrial Cancer. American Family Physician. 2009; 80: 1075-1080

6. Cameron ST, Walker J, Chambers S, Critchley H. Comparison of transvaginal ultrasound, saline infusion sonography and hysteroscopy to investigate postmenopausal bleeding and unscheduled bleeding on HRT. Aust N Z J Obstet Gynaecol 2001; 41: 291-4.

7. Chen L .M et al. (2012, August 13). Endometrial Carcinoma: Epidemiology and risk factors. Retrieved September 2, 2012

8. Clark T. J, Barton P, Coomarasamy,A. Gupta J, and Khan S, “Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies,” BJOG, vol. 113, no. 5, pp. 502–510, 2006.

9. Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002; 288: 1610-21

10. Coleman BG, Arger PH, Grumbach K, et al. Transvaginal and transabdominal sonography: prospective comparison. Radiology 1988; 168: 639-43

11. Dijkhuizen F. P, Diagnosis of Uterine Cavity Abnormalities. Studies on Test Performace and Clinical Value, Utrecht University, Utrecht, The Netherlands, 2000.

12. Giuntoli RL, Zacur HA. Management of Endometrial Hyperplasia. In: UpToDate, Goff, B (Ed), UpToDate, Waltham, MA, 2012.

13. Gupta J.K, Chien P, Voit D, Clark T.J, and Khan K. S, “Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis,” Acta Obstetricia et Gynecologica Scandinavica, vol. 81, no. 9, pp. 799–816, 2002.

14. Lin H, Wu M.Y, Shyu M. K, Chen D, Tsai J. L, and Hsieh C. Y, “Clinical study of 381 postmenopausal bleeding patients,” Journal of the Formosan Medical Association, vol. 92, no. 3, pp. 241–244, 1993.

15. Opmeer B, Van Doorn H, Heintz A, Burger C, Bossuyt P, and Mol B, “Improving the existing diagnostic strategy by accounting for characteristics of the women in the diagnostic work up for postmenopausal bleeding,” BJOG, vol. 114, no. 1, pp. 51–58, 2007.

16. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998; 280: 1510-17

17. Stewart EA. Endometrial Polyps. In: UpToDate, Barbieri, RL (Ed), UpToDate, Waltham, MA, 2012.

18. Stewart EA. Overview of treatment of Uterine Leiomyomas (Fibroids). In: UpToDate, Barbieri, RL (Ed), UpToDate, Waltham, MA, 2012.

19. Timmermans A, Veersema S, Van Kerkvoorde T, et al., “Should endometrial polyps be removed in patients with postmenopausal bleeding?–an assessment of study designs and report of a failed randomised controlled trial (ISRCTN73825127),” BJOG, vol. 116, no. 10, pp. 1391–1395, 2009.

20. Tsai MC, Goldstein SR. Office Diagnosis and Management of Abnormal Uterine Bleeding. Clinical Obstetrics and Gynecology 2012; 55: 635-650.